Corcept Therapeutics Announces Third Quarter Results and Corporate and Development Update
[at noodls] – MENLO PARK, Calif. – October 31, 2012 Corcept Therapeutics Incorporated (CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe … moreView todays social media effects on CORTView the latest stocks trending across Twitter. Click to view dashboard […]
